メインコンテンツにスキップ
検索

後期臨床

登録

最新のリソース

注目コンテンツ

Upcoming late clinical webinars

Latest late clinical blogs

以下のイベントで弊社のエキスパートをご紹介

All late clinical resources

Everything You Need to Know About CRFs in Clinical Trials

Certara Products, Certara Products - Pinnacle 21, Clinical Trial Software, Clinical Trials, CRF Design, Data Standards, Blog

ライフサイエンスにおける AI プロンプトエンジニアリングのベストプラクティス

AI, Certara Products, Certara.AI, Blog

Population Pharmacokinetic Modeling of Niraparib to Assess Different Absorption Models

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Oncology/Hematology, Therapeutic Specialties, Publication

Controlling Clinical Data from Collection to Submission

AI, Certara Products, Certara Products - GlobalSubmit, Certara Products - Pinnacle 21, Certara.AI, Data Standards, On-Demand Webinar

FDA Rebuilding After DOGE Cuts: Former Regulators Speak Out

New Approach Methodologies (NAMs), Press Coverage

Minimize risk when preparing for hepatic impairment studies

Certara Products - Simcyp, Clinical Pharmacology, Clinical Trials, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Webinar

PBPK Modeling in Pregnancy: Improving Drug Dosing Without Clinical Trials

Certara Products - Simcyp, Modeling and Simulation - PBPK, Press Coverage

4 Key Principles of Effective Pharmacokinetic Data Reporting

ブログ

Pharmacometrics Under Pressure Part 2 – The Steady Miles: Project-Grade PMx Without Losing Pace

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, On-Demand Webinar

Why CROs should use Pinnacle 21 Enterprise for late phase clinical data validation

Certara Products - Pinnacle 21, Blog

Population Pharmacodynamic Modeling of Plozasiran for Treatment of Familial Chylomicronemia Syndrome

Cardiovascular, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication

Population Pharmacokinetics and Exposure-Response Analysis of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication
ニュースレターを購読

今すぐ登録：医薬品開発の革新は、サターラの情熱そのものです。最新情報を入手し、ともに科学の限界を切り拓いていきましょう。


Powered by Translations.com GlobalLink Web Software